451 related articles for article (PubMed ID: 28408402)
1. Poly-GP in cerebrospinal fluid links
Lehmer C; Oeckl P; Weishaupt JH; Volk AE; Diehl-Schmid J; Schroeter ML; Lauer M; Kornhuber J; Levin J; Fassbender K; Landwehrmeyer B; ; Schludi MH; Arzberger T; Kremmer E; Flatley A; Feederle R; Steinacker P; Weydt P; Ludolph AC; Edbauer D; Otto M
EMBO Mol Med; 2017 Jul; 9(7):859-868. PubMed ID: 28408402
[TBL] [Abstract][Full Text] [Related]
2. Development of a sensitive trial-ready poly(GP) CSF biomarker assay for
Wilson KM; Katona E; Glaria I; Carcolé M; Swift IJ; Sogorb-Esteve A; Heller C; Bouzigues A; Heslegrave AJ; Keshavan A; Knowles K; Patil S; Mohapatra S; Liu Y; Goyal J; Sanchez-Valle R; Laforce RJ; Synofzik M; Rowe JB; Finger E; Vandenberghe R; Butler CR; Gerhard A; Van Swieten JC; Seelaar H; Borroni B; Galimberti D; de Mendonça A; Masellis M; Tartaglia MC; Otto M; Graff C; Ducharme S; Schott JM; Malaspina A; Zetterberg H; Boyanapalli R; Rohrer JD; Isaacs AM;
J Neurol Neurosurg Psychiatry; 2022 Jul; 93(7):761-771. PubMed ID: 35379698
[TBL] [Abstract][Full Text] [Related]
3. Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.
McEachin ZT; Gendron TF; Raj N; García-Murias M; Banerjee A; Purcell RH; Ward PJ; Todd TW; Merritt-Garza ME; Jansen-West K; Hales CM; García-Sobrino T; Quintáns B; Holler CJ; Taylor G; San Millán B; Teijeira S; Yamashita T; Ohkubo R; Boulis NM; Xu C; Wen Z; Streichenberger N; ; Fogel BL; Kukar T; Abe K; Dickson DW; Arias M; Glass JD; Jiang J; Tansey MG; Sobrido MJ; Petrucelli L; Rossoll W; Bassell GJ
Neuron; 2020 Jul; 107(2):292-305.e6. PubMed ID: 32375063
[TBL] [Abstract][Full Text] [Related]
4. Repeated repeat problems: Combinatorial effect of C9orf72-derived dipeptide repeat proteins.
Darling AL; Breydo L; Rivas EG; Gebru NT; Zheng D; Baker JD; Blair LJ; Dickey CA; Koren J; Uversky VN
Int J Biol Macromol; 2019 Apr; 127():136-145. PubMed ID: 30639592
[TBL] [Abstract][Full Text] [Related]
5. Poly(GR) and poly(GA) in cerebrospinal fluid as potential biomarkers for C9ORF72-ALS/FTD.
Krishnan G; Raitcheva D; Bartlett D; Prudencio M; McKenna-Yasek DM; Douthwright C; Oskarsson BE; Ladha S; King OD; Barmada SJ; Miller TM; Bowser R; Watts JK; Petrucelli L; Brown RH; Kankel MW; Gao FB
Nat Commun; 2022 May; 13(1):2799. PubMed ID: 35589711
[TBL] [Abstract][Full Text] [Related]
6. Translation of dipeptide repeat proteins in
Sonobe Y; Lee S; Krishnan G; Gu Y; Kwon DY; Gao FB; Roos RP; Kratsios P
Elife; 2023 Sep; 12():. PubMed ID: 37675986
[TBL] [Abstract][Full Text] [Related]
7. BET bromodomain inhibitors PFI-1 and JQ1 are identified in an epigenetic compound screen to enhance C9ORF72 gene expression and shown to ameliorate C9ORF72-associated pathological and behavioral abnormalities in a C9ALS/FTD model.
Quezada E; Cappelli C; Diaz I; Jury N; Wightman N; Brown RH; Montecino M; van Zundert B
Clin Epigenetics; 2021 Mar; 13(1):56. PubMed ID: 33726839
[TBL] [Abstract][Full Text] [Related]
8. Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity.
Quaegebeur A; Glaria I; Lashley T; Isaacs AM
Acta Neuropathol Commun; 2020 Nov; 8(1):184. PubMed ID: 33168090
[TBL] [Abstract][Full Text] [Related]
9. Poly(GP) proteins are a useful pharmacodynamic marker for
Gendron TF; Chew J; Stankowski JN; Hayes LR; Zhang YJ; Prudencio M; Carlomagno Y; Daughrity LM; Jansen-West K; Perkerson EA; O'Raw A; Cook C; Pregent L; Belzil V; van Blitterswijk M; Tabassian LJ; Lee CW; Yue M; Tong J; Song Y; Castanedes-Casey M; Rousseau L; Phillips V; Dickson DW; Rademakers R; Fryer JD; Rush BK; Pedraza O; Caputo AM; Desaro P; Palmucci C; Robertson A; Heckman MG; Diehl NN; Wiggs E; Tierney M; Braun L; Farren J; Lacomis D; Ladha S; Fournier CN; McCluskey LF; Elman LB; Toledo JB; McBride JD; Tiloca C; Morelli C; Poletti B; Solca F; Prelle A; Wuu J; Jockel-Balsarotti J; Rigo F; Ambrose C; Datta A; Yang W; Raitcheva D; Antognetti G; McCampbell A; Van Swieten JC; Miller BL; Boxer AL; Brown RH; Bowser R; Miller TM; Trojanowski JQ; Grossman M; Berry JD; Hu WT; Ratti A; Traynor BJ; Disney MD; Benatar M; Silani V; Glass JD; Floeter MK; Rothstein JD; Boylan KB; Petrucelli L
Sci Transl Med; 2017 Mar; 9(383):. PubMed ID: 28356511
[TBL] [Abstract][Full Text] [Related]
10. Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with
Barschke P; Oeckl P; Steinacker P; Al Shweiki MR; Weishaupt JH; Landwehrmeyer GB; Anderl-Straub S; Weydt P; Diehl-Schmid J; Danek A; Kornhuber J; Schroeter ML; Prudlo J; Jahn H; Fassbender K; Lauer M; van der Ende EL; van Swieten JC; Volk AE; Ludolph AC; Otto M;
J Neurol Neurosurg Psychiatry; 2020 May; 91(5):503-511. PubMed ID: 32132225
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal imaging in
Floeter MK; Bageac D; Danielian LE; Braun LE; Traynor BJ; Kwan JY
Neuroimage Clin; 2016; 12():1035-1043. PubMed ID: 27995069
[TBL] [Abstract][Full Text] [Related]
12. Poly-PR in C9ORF72-Related Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Causes Neurotoxicity by Clathrin-Dependent Endocytosis.
Wang R; Xu X; Hao Z; Zhang S; Wu D; Sun H; Mu C; Ren H; Wang G
Neurosci Bull; 2019 Oct; 35(5):889-900. PubMed ID: 31148094
[TBL] [Abstract][Full Text] [Related]
13. An update on genetic frontotemporal dementia.
Greaves CV; Rohrer JD
J Neurol; 2019 Aug; 266(8):2075-2086. PubMed ID: 31119452
[TBL] [Abstract][Full Text] [Related]
14. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
Farg MA; Konopka A; Soo KY; Ito D; Atkin JD
Hum Mol Genet; 2017 Aug; 26(15):2882-2896. PubMed ID: 28481984
[TBL] [Abstract][Full Text] [Related]
15. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases.
Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR
Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419
[TBL] [Abstract][Full Text] [Related]
16. Inflammasome-Mediated Neuronal-Microglial Crosstalk: a Therapeutic Substrate for the Familial C9orf72 Variant of Frontotemporal Dementia/Amyotrophic Lateral Sclerosis.
Trageser KJ; Yang EJ; Smith C; Iban-Arias R; Oguchi T; Sebastian-Valverde M; Iqbal UH; Wu H; Estill M; Al Rahim M; Raval U; Herman FJ; Zhang YJ; Petrucelli L; Pasinetti GM
Mol Neurobiol; 2023 Jul; 60(7):4004-4016. PubMed ID: 37010807
[TBL] [Abstract][Full Text] [Related]
17. Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice.
Peters OM; Cabrera GT; Tran H; Gendron TF; McKeon JE; Metterville J; Weiss A; Wightman N; Salameh J; Kim J; Sun H; Boylan KB; Dickson D; Kennedy Z; Lin Z; Zhang YJ; Daughrity L; Jung C; Gao FB; Sapp PC; Horvitz HR; Bosco DA; Brown SP; de Jong P; Petrucelli L; Mueller C; Brown RH
Neuron; 2015 Dec; 88(5):902-909. PubMed ID: 26637797
[TBL] [Abstract][Full Text] [Related]
18. C9orf72 ALS/FTD dipeptide repeat protein levels are reduced by small molecules that inhibit PKA or enhance protein degradation.
Licata NV; Cristofani R; Salomonsson S; Wilson KM; Kempthorne L; Vaizoglu D; D'Agostino VG; Pollini D; Loffredo R; Pancher M; Adami V; Bellosta P; Ratti A; Viero G; Quattrone A; Isaacs AM; Poletti A; Provenzani A
EMBO J; 2022 Jan; 41(1):e105026. PubMed ID: 34791698
[TBL] [Abstract][Full Text] [Related]
19. Dipeptide repeat derived from C9orf72 hexanucleotide expansions forms amyloids or natively unfolded structures in vitro.
Brasseur L; Coens A; Waeytens J; Melki R; Bousset L
Biochem Biophys Res Commun; 2020 May; 526(2):410-416. PubMed ID: 32223927
[TBL] [Abstract][Full Text] [Related]
20. C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity.
Lee YB; Baskaran P; Gomez-Deza J; Chen HJ; Nishimura AL; Smith BN; Troakes C; Adachi Y; Stepto A; Petrucelli L; Gallo JM; Hirth F; Rogelj B; Guthrie S; Shaw CE
Hum Mol Genet; 2017 Dec; 26(24):4765-4777. PubMed ID: 28973350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]